Inmaculada C.
- Country
- Spain
- Department
- Medicina Interna
Research Overview
- Evaluation of Preemptive Genotyping Strategy on Statin-Induced Musculoskeletal Adverse Events in Cardiovascular Risk Patients Using Atorvastatin and Drug Combination
- An Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients with Severe Hypertriglyceridemia (SHTG)
Data & Insights
Has run more than one trial at 2 of 138 partner sites.
Specializations
Lipid Disorders
The investigator specializes in treating patients with severe hypertriglyceridemia (SHTG), focusing on innovative therapeutic approaches for managing elevated triglyceride levels.
- Triglyceride Level Management
- Novel Lipid-Lowering Therapies
- Metabolic Disorder Treatment
Particular expertise in evaluating emerging treatments for severe lipid disorders and their clinical implications.
Cardiovascular Disease
Focuses on the intersection of hypertriglyceridemia and atherosclerotic cardiovascular disease, investigating therapeutic solutions for patients with complex cardiovascular conditions.
- Atherosclerosis Management
- Cardiovascular Risk Assessment
- Preventive Cardiology
Dedicated to advancing treatment strategies for patients with combined cardiovascular and metabolic conditions.
Personalized Medicine
Explores gene analysis strategies in cardiovascular disease treatment, with emphasis on optimizing statin therapy through genetic profiling.
- Pharmacogenetic Testing
- Statin Response Analysis
- Risk Stratification
Specializes in developing personalized treatment approaches for cardiovascular disease prevention and management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.